Industrials

ROCHE

In June 2009, I-Stem and Roche have signed a collaboration agreement for three years. The objective of this agreement is to discover new therapies to treat central nervous system diseases such as Alzheimer’s disease, schizophrenia, depression and anxiety. This collaboration enables Roche to use the techniques of proliferation of neural stem cells developed by I-Stem to screen libraries of compounds from Roche and identify molecules that could be potentially useful in the treatment of neurodegenerative diseases.

Stem cells and their applications offer great potential for the discovery of drugs or therapies. I-Stem is a pioneer in this field and the development of cellular models that can be used as a basis for screening libraries of compounds.

I-Stem and Roche hear this collaboration to work together in the central nervous system to provide effective treatments for patients. Implementation of the program is carried out in close collaboration between scientists based in Basel, Switzerland for ROCHE and in Evry (Paris) for I-Stem .